APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Coronary CT Angiography(CCTA) Analysis Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Outlook and Growth Opportunities 2026

2 May 2026199 pages

Choose your research edition.

Industry ResearchAI Coronary CT Angiography(CCTA) Analysis Platform Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Coronary CT Angiography(CCTA) Analysis Platform Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal AI Coronary CT Angiography(CCTA) Analysis Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Coronary CT Angiography(CCTA) Analysis Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Coronary CT Angiography(CCTA) Analysis Platform Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global AI Coronary CT Angiography(CCTA) Analysis Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Coronary CT Angiography(CCTA) Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Coronary CT Angiography(CCTA) Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Coronary CT Angiography(CCTA) Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Coronary CT Angiography(CCTA) Analysis Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Coronary CT Angiography(CCTA) Analysis Platform market include Medis Medical Imaging, Cleerly, Heartflow, Artrya, Spimed-AI, Caristo Diagnostics, RSIP Vision, Circle and RadNet, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Coronary CT Angiography(CCTA) Analysis Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Coronary CT Angiography(CCTA) Analysis Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Coronary CT Angiography(CCTA) Analysis Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Coronary CT Angiography(CCTA) Analysis Platform market.

AI Coronary CT Angiography(CCTA) Analysis Platform Segment by Company

Medis Medical Imaging

Cleerly

Heartflow

Artrya

Spimed-AI

Caristo Diagnostics

RSIP Vision

Circle

RadNet

Shanghai United-Imaging

Shukun (Beijing) Technology

Shenzhen Ruixin Intelligent Medical Technology

AI Coronary CT Angiography(CCTA) Analysis Platform Segment by Type

Cloud-based Software

On-premise Software

AI Coronary CT Angiography(CCTA) Analysis Platform Segment by Application

Medical Research

Clinical Application

AI Coronary CT Angiography(CCTA) Analysis Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Coronary CT Angiography(CCTA) Analysis Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Coronary CT Angiography(CCTA) Analysis Platform key companies, revenue, market share, and recent developments.

3. To split the AI Coronary CT Angiography(CCTA) Analysis Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Coronary CT Angiography(CCTA) Analysis Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Coronary CT Angiography(CCTA) Analysis Platform significant trends, drivers, influence factors in global and regions.

6. To analyze AI Coronary CT Angiography(CCTA) Analysis Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Coronary CT Angiography(CCTA) Analysis Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Coronary CT Angiography(CCTA) Analysis Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Coronary CT Angiography(CCTA) Analysis Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Coronary CT Angiography(CCTA) Analysis Platform industry.

Chapter 3: Detailed analysis of AI Coronary CT Angiography(CCTA) Analysis Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Coronary CT Angiography(CCTA) Analysis Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Coronary CT Angiography(CCTA) Analysis Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Coronary CT Angiography(CCTA) Analysis Platform Industry Trends Table 2. AI Coronary CT Angiography(CCTA) Analysis Platform Industry Drivers Table 3. AI Coronary CT Angiography(CCTA) Analysis Platform Industry Opportunities and Challenges Table 4. AI Coronary CT Angiography(CCTA) Analysis Platform Industry Restraints Table 5. Global AI Coronary CT Angiography(CCTA) Analysis Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Coronary CT Angiography(CCTA) Analysis Platform Revenue Share by Company (2021-2026) Table 7. Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Coronary CT Angiography(CCTA) Analysis Platform Key Company Manufacturing Base & Headquarters Table 9. Global AI Coronary CT Angiography(CCTA) Analysis Platform Company, Product Type & Application Table 10. Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Coronary CT Angiography(CCTA) Analysis Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Software Table 15. Significant Companies of On-premise Software Table 16. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type (2021-2026) Table 20. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Research Table 22. Significant Companies of Clinical Application Table 23. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application (2021-2026) Table 27. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application (2027-2032) Table 28. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Region (2021-2026) Table 31. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Region (2027-2032) Table 33. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Market Share by Country (2021-2026) Table 36. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Market Share by Country (2027-2032) Table 38. Medis Medical Imaging Company Information Table 39. Medis Medical Imaging Business Overview Table 40. Medis Medical Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Medis Medical Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 42. Medis Medical Imaging Recent Development Table 43. Cleerly Company Information Table 44. Cleerly Business Overview Table 45. Cleerly AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Cleerly AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 47. Cleerly Recent Development Table 48. Heartflow Company Information Table 49. Heartflow Business Overview Table 50. Heartflow AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Heartflow AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 52. Heartflow Recent Development Table 53. Artrya Company Information Table 54. Artrya Business Overview Table 55. Artrya AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Artrya AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 57. Artrya Recent Development Table 58. Spimed-AI Company Information Table 59. Spimed-AI Business Overview Table 60. Spimed-AI AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Spimed-AI AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 62. Spimed-AI Recent Development Table 63. Caristo Diagnostics Company Information Table 64. Caristo Diagnostics Business Overview Table 65. Caristo Diagnostics AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Caristo Diagnostics AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 67. Caristo Diagnostics Recent Development Table 68. RSIP Vision Company Information Table 69. RSIP Vision Business Overview Table 70. RSIP Vision AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. RSIP Vision AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 72. RSIP Vision Recent Development Table 73. Circle Company Information Table 74. Circle Business Overview Table 75. Circle AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Circle AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 77. Circle Recent Development Table 78. RadNet Company Information Table 79. RadNet Business Overview Table 80. RadNet AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. RadNet AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 82. RadNet Recent Development Table 83. Shanghai United-Imaging Company Information Table 84. Shanghai United-Imaging Business Overview Table 85. Shanghai United-Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shanghai United-Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 87. Shanghai United-Imaging Recent Development Table 88. Shukun (Beijing) Technology Company Information Table 89. Shukun (Beijing) Technology Business Overview Table 90. Shukun (Beijing) Technology AI Coronary CT Angiography(CCTA) Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Shukun (Beijing) Technology AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 92. Shukun (Beijing) Technology Recent Development Table 93. Shenzhen Ruixin Intelligent Medical Technology Company Information Table 94. Shenzhen Ruixin Intelligent Medical Technology Business Overview Table 95. Shenzhen Ruixin Intelligent Medical Technology AI Coronary CT Angiography(CCTA) Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Shenzhen Ruixin Intelligent Medical Technology AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio Table 97. Shenzhen Ruixin Intelligent Medical Technology Recent Development Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. AI Coronary CT Angiography(CCTA) Analysis Platform Product Image Figure 2. Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Software Image Figure 8. On-premise Software Image Figure 9. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type (2021-2032) Figure 12. Medical Research Image Figure 13. Clinical Application Image Figure 14. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application (2021-2032) Figure 17. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 20. North America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 22. Europe AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 26. South America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based Software
  • On-premise Software
Applications
  • Medical Research
  • Clinical Application
Companies covered
  • Medis Medical Imaging
  • Cleerly
  • Heartflow
  • Artrya
  • Spimed-AI
  • Caristo Diagnostics
  • RSIP Vision
  • Circle
  • RadNet
  • Shanghai United-Imaging
  • Shukun (Beijing) Technology
  • Shenzhen Ruixin Intelligent Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Coronary CT Angiography(CCTA) Analysis Platform Market Dynamics
  1. 2.1 AI Coronary CT Angiography(CCTA) Analysis Platform Industry Trends
  2. 2.2 AI Coronary CT Angiography(CCTA) Analysis Platform Industry Drivers
  3. 2.3 AI Coronary CT Angiography(CCTA) Analysis Platform Industry Opportunities and Challenges
  4. 2.4 AI Coronary CT Angiography(CCTA) Analysis Platform Industry Restraints
3 AI Coronary CT Angiography(CCTA) Analysis Platform Market by Company
  1. 3.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Revenue Ranking in 2025
  2. 3.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Revenue by Company (2021-2026)
  3. 3.3 Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Ranking (2024-2026)
  4. 3.4 Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Product Type and Application
  6. 3.6 Global AI Coronary CT Angiography(CCTA) Analysis Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Coronary CT Angiography(CCTA) Analysis Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Coronary CT Angiography(CCTA) Analysis Platform Market by Type
  1. 4.1 AI Coronary CT Angiography(CCTA) Analysis Platform Type Introduction
  2. 4.1.1 Cloud-based Software
  3. 4.1.2 On-premise Software
  4. 4.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type
  5. 4.2.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type (2021-2032)
5 AI Coronary CT Angiography(CCTA) Analysis Platform Market by Application
  1. 5.1 AI Coronary CT Angiography(CCTA) Analysis Platform Application Introduction
  2. 5.1.1 Medical Research
  3. 5.1.2 Clinical Application
  4. 5.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application
  5. 5.2.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Application (2021-2032)
  7. 5.2.3 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application (2021-2032)
6 AI Coronary CT Angiography(CCTA) Analysis Platform Regional Value Analysis
  1. 6.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032)
  7. 6.3.2 North America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032)
  10. 6.4.2 Europe AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032)
  16. 6.6.2 South America AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Country, 2025 VS 2032
7 AI Coronary CT Angiography(CCTA) Analysis Platform Country-level Value Analysis
  1. 7.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Coronary CT Angiography(CCTA) Analysis Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medis Medical Imaging
  2. 8.1.1 Medis Medical Imaging Company Information
  3. 8.1.2 Medis Medical Imaging Business Overview
  4. 8.1.3 Medis Medical Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medis Medical Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  6. 8.1.5 Medis Medical Imaging Recent Developments
  7. 8.2 Cleerly
  8. 8.2.1 Cleerly Company Information
  9. 8.2.2 Cleerly Business Overview
  10. 8.2.3 Cleerly AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cleerly AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  12. 8.2.5 Cleerly Recent Developments
  13. 8.3 Heartflow
  14. 8.3.1 Heartflow Company Information
  15. 8.3.2 Heartflow Business Overview
  16. 8.3.3 Heartflow AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Heartflow AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  18. 8.3.5 Heartflow Recent Developments
  19. 8.4 Artrya
  20. 8.4.1 Artrya Company Information
  21. 8.4.2 Artrya Business Overview
  22. 8.4.3 Artrya AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Artrya AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  24. 8.4.5 Artrya Recent Developments
  25. 8.5 Spimed-AI
  26. 8.5.1 Spimed-AI Company Information
  27. 8.5.2 Spimed-AI Business Overview
  28. 8.5.3 Spimed-AI AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Spimed-AI AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  30. 8.5.5 Spimed-AI Recent Developments
  31. 8.6 Caristo Diagnostics
  32. 8.6.1 Caristo Diagnostics Company Information
  33. 8.6.2 Caristo Diagnostics Business Overview
  34. 8.6.3 Caristo Diagnostics AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Caristo Diagnostics AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  36. 8.6.5 Caristo Diagnostics Recent Developments
  37. 8.7 RSIP Vision
  38. 8.7.1 RSIP Vision Company Information
  39. 8.7.2 RSIP Vision Business Overview
  40. 8.7.3 RSIP Vision AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RSIP Vision AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  42. 8.7.5 RSIP Vision Recent Developments
  43. 8.8 Circle
  44. 8.8.1 Circle Company Information
  45. 8.8.2 Circle Business Overview
  46. 8.8.3 Circle AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Circle AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  48. 8.8.5 Circle Recent Developments
  49. 8.9 RadNet
  50. 8.9.1 RadNet Company Information
  51. 8.9.2 RadNet Business Overview
  52. 8.9.3 RadNet AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RadNet AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  54. 8.9.5 RadNet Recent Developments
  55. 8.10 Shanghai United-Imaging
  56. 8.10.1 Shanghai United-Imaging Company Information
  57. 8.10.2 Shanghai United-Imaging Business Overview
  58. 8.10.3 Shanghai United-Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai United-Imaging AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  60. 8.10.5 Shanghai United-Imaging Recent Developments
  61. 8.11 Shukun (Beijing) Technology
  62. 8.11.1 Shukun (Beijing) Technology Company Information
  63. 8.11.2 Shukun (Beijing) Technology Business Overview
  64. 8.11.3 Shukun (Beijing) Technology AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shukun (Beijing) Technology AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  66. 8.11.5 Shukun (Beijing) Technology Recent Developments
  67. 8.12 Shenzhen Ruixin Intelligent Medical Technology
  68. 8.12.1 Shenzhen Ruixin Intelligent Medical Technology Company Information
  69. 8.12.2 Shenzhen Ruixin Intelligent Medical Technology Business Overview
  70. 8.12.3 Shenzhen Ruixin Intelligent Medical Technology AI Coronary CT Angiography(CCTA) Analysis Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shenzhen Ruixin Intelligent Medical Technology AI Coronary CT Angiography(CCTA) Analysis Platform Product Portfolio
  72. 8.12.5 Shenzhen Ruixin Intelligent Medical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst